Free Trial

Quipt Home Medical Q4 2024 Earnings Report

Quipt Home Medical logo
$2.54 -0.06 (-2.31%)
As of 02/21/2025 04:00 PM Eastern

Quipt Home Medical EPS Results

Actual EPS
-$0.07
Consensus EPS
$0.01
Beat/Miss
Missed by -$0.08
One Year Ago EPS
N/A

Quipt Home Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Quipt Home Medical Announcement Details

Quarter
Q4 2024
Time
After Market Closes

Quipt Home Medical Earnings Headlines

Reviewing Quipt Home Medical (NASDAQ:QIPT) & Mangoceuticals (NASDAQ:MGRX)
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.
Quipt Home Medical Corp. (QIPT): A Bull Case Theory
See More Quipt Home Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Quipt Home Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quipt Home Medical and other key companies, straight to your email.

About Quipt Home Medical

Quipt Home Medical (NASDAQ:QIPT), through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

View Quipt Home Medical Profile

More Earnings Resources from MarketBeat